Skip to main content

Metabolic Effects of the Bile Acid Sequestrant Polidexide (SecholexR) in Man

  • Chapter
Atherosclerosis

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 82))

  • 20 Accesses

Abstract

Cholestyramine has an accepted place in the treatment of hypercholesterolemia, acting as a non-absorbable bile acid sequestrant. Although it is effective and safe during long-term administration, its use has been complicated by gastro-intestinal side-effects and by the occasional development or aggravation of hypertriglyceridemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Plenum Press, New York

About this chapter

Cite this chapter

Simons, L.A., Myant, N.B. (1977). Metabolic Effects of the Bile Acid Sequestrant Polidexide (SecholexR) in Man. In: Manning, G.W., Haust, M.D. (eds) Atherosclerosis. Advances in Experimental Medicine and Biology, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4220-5_35

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-4220-5_35

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4222-9

  • Online ISBN: 978-1-4613-4220-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics